Spontaneous_JJ Cytokine_NP Production_NP and_CC Its_PP$ Effect_NN on_IN Induced_NP Production_NP Cytokines_NP regulate_VB cellular_JJ immune_JJ activity_NN and_CC are_VBP produced_VBN by_IN a_DT variety_NN of_IN cells_NNS ,_, especially_RB lymphocytes_NNS ,_, monocytes_NNS ,_, and_CC macrophages_NNS ._SENT Multiparameter_NN flow_NN cytometry_NN is_VBZ often_RB used_VBN to_TO examine_VB cell-specific_JJ cytokine_NN production_NN after_IN in_IN vitro_NN phorbol_NN 12-myristate_JJ 13-acetate_NN and_CC ionomycin_NN induction_NN ,_, with_IN brefeldin_NP A_NP or_CC other_JJ agents_NNS added_VBD to_TO inhibit_VB protein_NN secretion_NN ._SENT Spontaneous_JJ ex_JJ vivo_JJ production_NN reportedly_RB rarely_RB occurs_VBZ ._SENT We_PP examined_VBD the_DT spontaneous_JJ production_NN of_IN interleukin_NN 2_CD (_( IL-2_NP )_) ,_, IL-4_NN ,_, IL-6_NP ,_, IL-8_NP ,_, IL-10_NP ,_, tumor_NN necrosis_NN factor_NN alpha_NN (_( TNF-alpha_NP )_) ,_, and_CC gamma_NN interferon_NN (_( IFN-gamma_NP )_) by_IN peripheral-blood_JJ B_NP lymphocytes_NNS ,_, T_NN cells_NNS ,_, CD8-_NP T_NN cells_NNS ,_, CD8+_NP T_NN cells_NNS ,_, CD3-_NP CD16/56+_NP lymphocytes_NNS (_( natural_JJ killer_NN [_SYM NK_NP ]_SYM cells_NNS )_) ,_, CD3+_NP CD16/56+_NP lymphocytes_NNS (_( natural_JJ T_NN [_SYM NT_NP ]_SYM cells_NNS )_) ,_, and/or_CC monocytes_NNS of_IN 316_CD acutely_RB ill_RB hospitalized_VBN persons_NNS and_CC 62_CD healthy_JJ adults_NNS in_IN Malawi_NP ,_, Africa_NP ._SENT We_PP also_RB evaluated_VBD the_DT relationship_NN between_IN spontaneous_JJ and_CC induced_VBN cytokine_NN production_NN ._SENT In_IN patients_NNS ,_, spontaneous_JJ TNF-alpha_NP production_NN occurred_VBD most_RBS frequently_RB ,_, followed_VBN in_IN descending_VBG order_NN by_IN IFN-gamma_NP ,_, IL-8_NP ,_, IL-4_NN ,_, IL-10_NP ,_, IL-6_NP ,_, and_CC IL-2_NP ._SENT Various_JJ cells_NNS of_IN 60_CD patients_NNS spontaneously_RB produced_VBN TNF-alpha_NP ;_: for_IN 12_CD of_IN these_DT patients_NNS ,_, TNF-alpha_NP was_VBD the_DT only_JJ cytokine_NN produced_VBN spontaneously_RB ._SENT Spontaneous_JJ cytokine_NN production_NN was_VBD most_RBS frequent_JJ in_IN the_DT immunoregulatory_JJ cells_NNS ,_, NK_NP and_CC NT_NP ._SENT For_IN IL-2_NP ,_, IL-4_NN ,_, IL-6_NP ,_, IL-8_NP ,_, and_CC IL-10_NP ,_, spontaneous_JJ cytokine_NN production_NN was_VBD associated_VBN with_IN greater_JJR induced_VBN production_NN ._SENT For_IN TNF-alpha_NP and_CC IFN-gamma_NP ,_, the_DT relationships_NNS varied_VBN by_IN cell_NN type_NN ._SENT For_IN healthy_JJ adults_NNS ,_, IL-6_NP was_VBD the_DT cytokine_NN most_RBS often_RB produced_VBN spontaneously_RB ._SENT Spontaneous_JJ cytokine_NN production_NN was_VBD not_RB unusual_JJ in_IN these_DT acutely_RB ill_JJ and_CC healthy_JJ persons_NNS living_VBG in_IN an_DT area_NN where_WRB human_JJ immunodeficiency_NN virus_NN ,_, mycobacterial_NN ,_, malaria_NN ,_, and_CC assorted_JJ parasitic_JJ infections_NNS are_VBP endemic_JJ ._SENT In_IN such_JJ populations_NNS ,_, spontaneous_JJ ,_, as_RB well_RB as_IN induced_VBN ,_, cell-specific_JJ cytokine_NN production_NN should_MD be_VB measured_VBN and_CC evaluated_VBN in_IN relation_NN to_TO various_JJ disease_NN states_NNS ._SENT Cytokines_NNS regulate_VBP cellular_JJ immune_JJ interactions_NNS and_CC are_VBP produced_VBN by_IN lymphocytes_NNS ,_, monocytes_NNS ,_, macrophages_NNS ,_, and_CC ,_, for_IN some_DT cytokines_NNS ,_, also_RB fibroblasts_NNS ,_, neutrophils_NNS ,_, endothelial_JJ cells_NNS ,_, or_CC mast_NN cells_NNS (_( for_IN a_DT review_NN ,_, see_VBP reference_NN )_) ._SENT Cytokines_NNS function_VBP on_IN a_DT microenvironmental_JJ level_NN ,_, but_CC human_JJ cytokines_NNS are_VBP most_RBS commonly_RB assessed_VBN at_IN the_DT macro_NN level_NN by_IN measuring_VBG their_PP$ levels_NNS in_IN serum_NN or_CC plasma_NN or_CC in_IN the_DT supernatant_JJ of_IN in_IN vitro-stimulated_JJ blood_NN cells_NNS ._SENT In_IN recent_JJ years_NNS ,_, improved_VBN reagents_NNS have_VBP permitted_VBN flow_NN cytometric_JJ cell-specific_JJ cytokine_NN assessments_NNS in_IN which_WDT peripheral_JJ blood_NN mononuclear_JJ cells_NNS (_( PBMCs_NP )_) are_VBP stimulated_VBN ex_JJ vivo_RB in_IN the_DT presence_NN of_IN an_DT agent_NN to_TO inhibit_VB protein_NN secretion_NN ._SENT This_DT stimulation_NN is_VBZ followed_VBN by_IN cell_NN permeabilization_NN ,_, fixation_NN ,_, fluorescent_JJ staining_VBG ,_, and_CC cytokine_NN detection_NN ._SENT With_IN multiparameter_NN flow_NN cytometry_NN ,_, specific_JJ cell_NN populations_NNS can_MD be_VB identified_VBN by_IN surface_NN antigen_NN staining_VBG and_CC examined_VBN for_IN cytokine_JJ production_NN without_IN cell_NN separation_NN or_CC cloning_VBG ._SENT Unstimulated_JJ cells_NNS are_VBP usually_RB run_VBN in_IN parallel_NN ,_, as_IN a_DT negative_JJ control_NN and_CC to_TO assist_VB in_IN setting_VBG quadrants_NNS for_IN assessing_VBG positivity_NN ,_, much_RB as_RB is_VBZ done_VBN with_IN an_DT isotype_NN control_NN ._SENT Spontaneous_JJ ex_JJ vivo_JJ cytokine_NN production_NN by_IN PBMCs_NP has_VBZ been_VBN reported_VBN not_RB to_TO occur_VB in_IN healthy_JJ individuals_NNS or_CC in_IN persons_NNS with_IN various_JJ disorders_NNS ,_, including_VBG allergic_JJ asthma_NN ,_, active_JJ and_CC inactive_JJ systemic_JJ lupus_NN erythematosus_NN ,_, and_CC sarcoidosis_NN ,_, and_CC those_DT recovering_VBG from_IN vascular_JJ surgery_NN ._SENT We_PP ourselves_PP have_VBP rarely_RB ,_, if_IN ever_RB ,_, noted_VBD spontaneous_JJ cytokine_NN production_NN in_IN PBMCs_NNS of_IN healthy_JJ U.S._NP blood_NN donors_NNS (_( reference_NN and_CC unpublished_JJ data_NNS )_) ._SENT However_RB ,_, in_IN a_DT multicenter_NN ,_, multiphase_JJ study_NN of_IN the_DT immune_JJ correlates_NNS of_IN bloodstream_NN infections_NNS in_IN developing_VBG countries_NNS ,_, we_PP noticed_VBD individuals_NNS whose_WP$ PBMCs_NNS produced_VBD cytokines_NNS without_IN stimulation_NN ._SENT Other_JJ researchers_NNS ,_, measuring_VBG either_DT protein_NN or_CC mRNA_NN ,_, have_VBP detected_VBN spontaneous_JJ cytokine_NN production_NN by_IN bronchoalveolar_JJ lavage_NN fluid_NN cells_NNS of_IN patients_NNS with_IN asthma_NN ,_, interacting_VBG umbilical_JJ vein_NN endothelial_JJ cells-monocyte_NN cells_NNS ,_, human_JJ milk_NN mononuclear_JJ cells_NNS ,_, peripheral_JJ blood_NN lymphocytes_NNS of_IN persons_NNS with_IN atopic_JJ dermatitis_NN ,_, peripheral_JJ blood_NN monocytes_NNS of_IN patients_NNS with_IN multiple_JJ sclerosis_NN ,_, or_CC CD4+_NP T_NN cells_NNS of_IN persons_NNS with_IN active_JJ Mycobacterium_NN tuberculosis_NN pulmonary_JJ infection_NN ._SENT The_DT presence_NN of_IN spontaneous_JJ cytokine_NN production_NN ex_NN vivo_RB implies_VBZ prior_RB in_IN vivo_JJ stimulation_NN ._SENT Since_IN the_DT process_NN of_IN cell_NN stimulation_NN often_RB leads_VBZ to_TO programmed_VBN cell_NN death_NN ,_, in_IN vivo_JJ stimulation_NN ,_, preceding_VBG in_IN vitro_NN stimulation_NN ,_, is_VBZ not_RB only_RB of_IN potential_JJ physiologic_JJ importance_NN but_CC may_MD also_RB be_VB of_IN practical_JJ importance_NN in_IN terms_NNS of_IN interpreting_VBG the_DT results_NNS of_IN in_IN vitro_NN stimulation_NN of_IN cytokine_NN production_NN ._SENT At_IN our_PP$ study_NN site_NN in_IN Malawi_NP ,_, Africa_NP ,_, we_PP acquired_VBD a_DT sufficient_JJ number_NN of_IN participants_NNS to_TO examine_VB spontaneous_JJ cytokine_NN production_NN in_IN some_DT depth_NN ._SENT For_IN this_DT study_NN ,_, we_PP defined_VBD spontaneous_JJ cytokine_NN production_NN in_IN a_DT simple_JJ ,_, quantitative_JJ manner_NN and_CC then_RB assessed_VBD the_DT cell_NN types_NNS spontaneously_RB producing_VBG cytokines_NNS ,_, the_DT cytokines_NNS and_CC cytokine_NN arrays_NNS being_VBG produced_VBN ,_, the_DT relationships_NNS between_IN spontaneous_JJ production_NN and_CC subsequent_JJ induced_VBN cytokine_NN production_NN ,_, and_CC the_DT relationship_NN between_IN spontaneous_JJ production_NN and_CC serum_NN cytokine_NN levels_NNS ._SENT Participants_NNS ._SENT |_SYM During_IN three_CD periods_NNS in_IN 1997_CD and_CC 1998_CD ,_, we_PP enrolled_VBD all_DT 561_CD febrile_JJ (_( oral_JJ temperature_NN ,_, >=38C_NN )_) adults_NNS (_( >=13_JJ years_NNS old_JJ )_) and_CC all_DT 244_CD acutely_RB ill_JJ children_NNS (_( <13_JJ years_NNS old_JJ )_) admitted_VBD to_TO Lilongwe_NP Central_NP Hospital_NP ,_, Malawi_NP ,_, Africa_NP ,_, into_IN a_DT study_NN of_IN bloodstream_NN infections_NNS ._SENT All_DT hospitalized_VBN children_NNS were_VBD included_VBN because_IN infected_JJ children_NNS often_RB do_VBP not_RB present_VB with_IN fever_NN ._SENT A_DT random_JJ subset_NN including_VBG 166_CD adult_NN and_CC 150_CD pediatric_JJ patients_NNS had_VBD immune_JJ studies_NNS done_VBN at_IN admission_NN ;_: this_DT subset_NN was_VBD comparable_JJ to_TO the_DT general_JJ study_NN population_NN and_CC was_VBD the_DT study_NN group_NN analyzed_VBD here_RB ._SENT Demographic_JJ ,_, epidemiological_JJ ,_, and_CC clinical_JJ data_NNS will_MD be_VB presented_VBN elsewhere_RB ._SENT We_PP also_RB enrolled_VBD 62_CD asymptomatic_JJ ,_, healthy_JJ ,_, employed_VBN adults_NNS ;_: children_NNS were_VBD not_RB included_VBN in_IN this_DT group_NN for_IN ethical_JJ reasons_NNS ._SENT Epidemiological_JJ data_NNS were_VBD not_RB obtained_VBN for_IN these_DT participants_NNS ._SENT The_DT study_NN protocol_NN was_VBD approved_VBN by_IN the_DT institutional_JJ review_NN boards_NNS of_IN the_DT Centers_NPS for_IN Disease_NP Control_NP and_CC Prevention_NP (_( CDC_NP )_) and_CC the_DT Malawian_JJ Health_NP Sciences_NPS Research_NP Committee_NP ;_: informed_JJ consent_NN was_VBD obtained_VBN from_IN all_DT participants_NNS and/or_CC their_PP$ guardians_NNS ._SENT As_IN in_IN most_JJS developing_VBG nations_NNS ,_, human_JJ immunodeficiency_NN virus_NN (HIV)-infected_VBD persons_NNS in_IN this_DT study_NN were_VBD neither_RB receiving_VBG antiviral_JJ therapies_NNS nor_CC being_VBG monitored_VBN for_IN changes_NNS in_IN CD4+-cell_NN counts_NNS or_CC HIV_NP RNA_NP levels_NNS in_IN plasma_NN ._SENT Laboratory_NN methods_NNS ._SENT (_( i_NP )_) Microbiological_NP ._SENT |_SYM HIV_NP antibody_NN testing_NN was_VBD done_VBN at_IN study_NN enrollment_NN ,_, using_VBG enzyme-linked_JJ immunosorbent_JJ assay_NN kits_NNS (_( Murex_NP Diagnostics_NP Inc._NP ,_, Norcross_NP ,_, Ga._NP )_) ._SENT HIV_NP type_NN 2_CD has_VBZ not_RB been_VBN reported_VBN in_IN Malawi_NP ._SENT Whole-blood_NP samples_NNS were_VBD cultured_VBN as_IN described_VBN previously_RB ._SENT (_( ii_NP )_) Cytokine_NP stimulation_NN ._SENT |_SYM Heparinized_JJ blood_NN was_VBD either_RB stimulated_VBN for_IN 5_CD h_NN at_IN 37C_JJ with_IN phorbol_NN 12-myristate_JJ 13-acetate_JJ (_( 200_CD ng/ml_NNS )_) (_( Sigma_NP Chemical_NP Co._NP ,_, St._NP Louis_NP ,_, Mo._NP )_) and_CC ionomycin_NN (_( 4_CD mug/ml_NN )_) (_( Sigma_NP )_) in_IN the_DT presence_NN of_IN brefeldin_NP A_NP (_( 40_CD mug/ml_NN )_) (_( Sigma_NP )_) and_CC RPMI_NP 1640_CD with_IN l-glutamine_NN (_( induced_VBN ,_, or_CC stimulated_VBN ,_, cytokine_NN expression_NN )_) or_CC retained_VBN in_IN identical_JJ medium_NN without_IN phorbol_NN 12-myristate_JJ 13-acetate_NN and_CC ionomycin_NN but_CC with_IN brefeldin_NN A_DT (_( spontaneous_JJ ,_, or_CC unstimulated_JJ ,_, cytokine_JJ expression_NN )_) ._SENT No_DT serum_NN was_VBD added_VBN to_TO the_DT cultures_NNS ._SENT After_IN being_VBG washed_VBN ,_, the_DT red_JJ blood_NN cells_NNS were_VBD lysed_VBN with_IN ammonium_NN chloride_NN solution_NN ,_, and_CC the_DT lymphocytes_NNS were_VBD permeabilized_VBN and_CC fixed_VBN using_VBG Permeafix_NP (_( Ortho_NP Diagnostic_NP Systems_NP ,_, Inc._NP ,_, Raritan_NP ,_, N.J._NP )_) ._SENT Cell_NN counts_NNS before_IN and_CC after_IN stimulation_NN could_MD not_RB be_VB done_VBN ,_, and_CC markers_NNS of_IN apoptosis_NN were_VBD not_RB assessed_VBN ;_: therefore_RB ,_, the_DT issue_NN of_IN programmed_JJ cell_NN death_NN could_MD not_RB be_VB addressed_VBN in_IN our_PP$ analyses_NNS ._SENT After_IN being_VBG processed_VBN ,_, samples_NNS were_VBD shipped_VBN at_IN 4_CD to_TO 8C_NP to_TO CDC_NP for_IN further_JJR analysis_NN ._SENT (_( iii_NP )_) Flow_NP cytometric_JJ reagents_NNS ._SENT |_SYM The_DT surface_NN antigens_NNS assessed_VBN in_IN this_DT study_NN were_VBD ones_NNS previously_RB shown_VBN in_IN our_PP$ laboratory_NN to_TO be_VB stable_JJ with_IN this_DT permeabilization-fixation_NN protocol_NN ,_, i.e._FW ,_, using_VBG these_DT techniques_NNS ,_, we_PP had_VBD comparable_JJ results_NNS for_IN the_DT surface-related_JJ antigens_NNS when_WRB staining_VBG was_VBD done_VBN either_DT pre-_NN or_CC postpermeabilization_NN ._SENT Fluorescein_NN isothiocyanate_NN (FITC)-conjugated_JJ ,_, phycoerythrin_NN (PE)-conjugated_NN ,_, peridinin_NN chlorophyll_NN protein-conjugated_JJ ,_, or_CC allophycocyanin_JJ (APC)-conjugated_JJ murine_JJ monoclonal_NN antibodies_NNS were_VBD obtained_VBN from_IN the_DT following_VBG sources_NNS :_: (_( i_NP )_) Becton_NP Dickinson_NP Immunocytometry_NP Systems/PharMingen_NP (_( BD/PMG_NP ;_: San_NP Jose_NP ,_, Calif._NP )_) (_( CD8-FITC_NP and_CC -PE_NNS [_SYM clone_NN SK1_NP ]_SYM ,_, CD3-peridinin_NP chlorophyll_NN protein_NN and_CC -APC_NN [_SYM clone_NN SK7_NP ]_SYM ,_, CD4-APC_NP [_SYM clone_NN SK3_NP ]_SYM ,_, CD45-FITC_NP [_SYM clone_NN 2D1_JJ ]_SYM ,_, CD19-APC_NP [_SYM clone_NN SJ25C1_NP ]_SYM ,_, CD14-PE_NP [_SYM clone_NN MoP9_NP ]_SYM ,_, CD16-PE_NP [_SYM clone_NN B73.1_NP ]_SYM ,_, CD56_NP [_SYM clone_NN MY31_NP ]_SYM ,_, interleukin_NN 4_CD [_SYM IL-4]-PE_NP [_SYM clone_NN 8D4-8_JJ ]_SYM ,_, IL-8-PE_NP [_SYM clone_NN G265-8_NP ]_SYM ,_, and_CC IL-10-PE_NP [_SYM clone_NN JES3-9D7_NP ]_SYM )_) ,_, (_( ii_NP )_) Research_NP and_CC Diagnostics_NP (_( Minneapolis_NP ,_, Minn._NP )_) (_( IL-6-PE_NP [_SYM clone_NN 1927.311_CD ]_SYM )_) ,_, and_CC (_( iii_NP )_) Immune_NP Source_NP (_( Reno_NP ,_, Nev._NP )_) (_( CD8-APC_NP [_SYM clone_NN KL.12_NP ]_SYM ,_, IL-2-APC_NP [_SYM clone_NN R-56.2_NP ]_SYM ,_, tumor_NN necrosis_NN factor_NN alpha_NN [_SYM TNF-alpha]-FITC_NP [_SYM clone_NN DTX.34_NP ]_SYM ,_, and_CC gamma_NN interferon_NN [_SYM IFN-gamma]-APC_NP [_SYM clone_NN 13.TR_NP ]_SYM )_) ._SENT Isotype_NN controls_NNS were_VBD obtained_VBN from_IN BD/PMG_NP ._SENT Stimulation_NN was_VBD confirmed_VBN using_VBG anti-CD69-FITC_NP [_SYM clone_NN L78_NP ]_SYM (_( BD_NP )_) ,_, and_CC permeabilization_NN was_VBD confirmed_VBN using_VBG anti-microtubulin_NNS [_SYM clone_NN DM1A_NP ]_SYM (_( Sigma_NP )_) custom_NN conjugated_VBN to_TO FITC_NP by_IN CalTag_NP ,_, South_NP San_NP Francisco_NP ,_, Calif._NP (_( iv_NP )_) Flow_NP cytometry_NN ._SENT |_SYM All_DT staining_VBG was_VBD done_VBN at_IN room_NN temperature_NN for_IN 30_CD min_NN in_IN the_DT dark_NN after_IN permeabilization_NN ,_, fixation_NN ,_, and_CC shipment_NN to_TO CDC_NP ._SENT Staining_VBG was_VBD followed_VBN by_IN a_DT buffered_VBN saline_JJ wash_NN ._SENT Four-color_JJ cytofluorometry_NN was_VBD done_VBN using_VBG a_DT single_JJ FACSort_NP (_( 1997_CD and_CC 1998_CD )_) or_CC FACSCalibur_NP (_( 1998_CD )_) cytometer_NN and_CC CellQuest_NN software_NN (_( BD/PMG_NP )_) ._SENT Between_IN 50,000_CD and_CC 80,000_CD ungated_JJ events_NNS were_VBD collected_VBN from_IN each_DT tube_NN in_IN the_DT panel_NN ._SENT Instrument_NN settings_NNS were_VBD standardized_VBN each_DT day_NN using_VBG CaliBRITE_NP Beads_NPS (_( BD_NP )_) and_CC chicken_NN red_JJ blood_NN cells_NNS (_( BioSure_NP Controls_NP ;_: Riese_NP Enterprises_NPS ,_, Inc._NP ,_, Grass_NP Valley_NP ,_, Calif._NP )_) ;_: these_DT settings_NNS varied_VBD little_RB within_IN each_DT phase_NN of_IN the_DT study_NN ._SENT (_( v_NN )_) Serum_NP cytokines_NNS ._SENT |_SYM Serum_NP samples_NNS were_VBD analyzed_VBN for_IN IL-2_NP ,_, IL-4_NN ,_, IL-6_NP ,_, IL-8_NP ,_, and_CC IL-10_NP (_( all_RB provided_VBN by_IN BD/PMG_NP )_) and_CC for_IN IFN-gamma_NP and_CC TNF-alpha_NP (_( both_CC provided_VBN by_IN Genzyme_NP Diagnostics_NP ,_, Cambridge_NP ,_, Mass._NP )_) by_IN enzyme-linked_JJ immunosorbent_JJ assays_NNS using_VBG pairs_NNS of_IN cytokine-specific_JJ monoclonal_NN antibodies_NNS according_VBG to_TO the_DT manufacturers_NNS '_POS instructions_NNS ._SENT Details_NNS are_VBP provided_VBN elsewhere_RB ._SENT No_DT healthy_JJ participants_NNS and_CC few_JJ children_NNS had_VBD serum_NN cytokines_NNS assessed_VBN (_( see_VB Results_NNS )_) ._SENT Analytic_JJ techniques_NNS ._SENT (_( i_NP )_) Definition_NP ._SENT |_SYM For_IN the_DT sake_NN of_IN simplicity_NN and_CC consistency_NN ,_, we_PP defined_VBD spontaneous_JJ cytokine_NN production_NN as_IN occurring_VBG if_IN the_DT percentage_NN of_IN a_DT particular_JJ cell_NN type_NN producing_VBG a_DT certain_JJ cytokine_NN was_VBD above_IN the_DT 95th_JJ percentile_NN for_IN the_DT entire_JJ pediatric_JJ or_CC adult_JJ patient_JJ group_NN ._SENT For_IN example_NN ,_, 7_CD of_IN 158_CD (_( <5%)_of 1.7_CD %_NN of_IN unstimulated_JJ CD3+_NP lymphocytes_NNS read_VBP as_IN being_VBG positive_JJ for_IN intracellular_JJ IL-2_NN ,_, and_CC 6_CD of_IN the_DT 150_CD (_( <5%)_pediatric 2.2_CD %_NN of_IN unstimulated_JJ CD3+_NP lymphocytes_NNS read_VBP as_IN being_VBG positive_JJ for_IN intracellular_JJ IL-2_NP ._SENT These_DT 13_CD individuals_NNS were_VBD classified_VBN as_IN having_VBG CD3+_NP lymphocytes_NNS spontaneously_RB making_VBG IL-2_NP ;_: the_DT remaining_VBG patients_NNS were_VBD classified_VBN as_IN having_VBG CD3+_NP lymphocytes_NNS that_WDT were_VBD not_RB spontaneously_RB making_VBG IL-2_NP ._SENT The_DT number_NN of_IN healthy_JJ participants_NNS producing_VBG cytokines_NNS spontaneously_RB was_VBD fairly_RB small_JJ ;_: the_DT results_NNS for_IN the_DT healthy_JJ participants_NNS will_MD be_VB provided_VBN separately_RB from_IN those_DT of_IN patients_NNS ._SENT (_( ii_NP )_) Cells_NP assessed_VBD ._SENT |_SYM For_IN each_DT participant_NN ,_, analyses_NNS were_VBD done_VBN for_IN all_DT lymphocytes_NNS and_CC various_JJ combinations_NNS of_IN CD3+_NP lymphocytes_NNS (_( T_NN cells_NNS )_) ,_, CD3+_NP CD8+_NP lymphocytes_NNS ,_, CD3+_NP CD8-_NP lymphocytes_NNS ,_, CD3+_NP CD16/56+_NP lymphocytes_NNS (_( natural_JJ T_NN [_SYM NT_NP ]_SYM cells_NNS )_) ,_, CD3-_NP CD16/56+_NP lymphocytes_NNS (_( natural_JJ killer_NN [_SYM NK_NP ]_SYM cells_NNS )_) ,_, CD19+_NP (_( B_NP )_) lymphocytes_NNS ,_, and_CC monocytes_NNS ,_, depending_VBG upon_IN the_DT tube_NN configuration_NN ._SENT The_DT tube_NN configurations_NNS varied_VBD slightly_RB among_IN the_DT three_CD phases_NNS of_IN the_DT study_NN ._SENT (_( iii_NP )_) Flow_NP analyses_NNS ._SENT |_SYM For_IN consistency_NN ,_, all_DT data_NNS in_IN this_DT study_NN concerning_VBG spontaneous_JJ cytokine_NN production_NN were_VBD based_VBN on_IN analyses_NNS of_IN flow_NN data_NNS by_IN a_DT single_JJ individual_NN ._SENT Quadrants_NNS were_VBD based_VBN on_IN both_DT isotype_NN controls_NNS and_CC parallel_JJ unstimulated_JJ samples_NNS ;_: these_DT quadrants_NNS did_VBD not_RB tend_VB to_TO vary_VB between_IN patients_NNS ._SENT An_DT example_NN of_IN an_DT instance_NN of_IN spontaneous_JJ cytokine_NN production_NN is_VBZ provided_VBN in_IN Fig._NN ._SENT Lymphocytes_NNS were_VBD defined_VBN on_IN the_DT basis_NN of_IN forward_NN and_CC side_NN scatter_NN ;_: monocytes_NNS were_VBD defined_VBN on_IN the_DT basis_NN of_IN a_DT wide_JJ gate_NN based_VBN on_IN forward_JJ and_CC side_JJ scatter_NN of_IN stimulated_VBN and_CC unstimulated_JJ CD14+_NP cells_NNS ._SENT (_( iv_NP )_) Statistical_NP techniques_NNS ._SENT |_SYM Comparisons_NP of_IN continuous_JJ variables_NNS between_IN those_DT with_IN and_CC without_IN spontaneous_JJ cytokine_NN production_NN were_VBD made_VBN using_VBG Wilcoxon_NP rank_JJ sum_NN tests_NNS ._SENT Correlations_NNS were_VBD assessed_VBN using_VBG Pearson_NP and_CC Spearman_NP correlation_NN coefficients_NNS (_( rp_NNS and_CC rs_NNS ,_, respectively_RB )_) ._SENT The_DT significance_NN level_NN was_VBD set_VBN at_IN 0.05_CD ._SENT FIG._NN 1_CD ._SENT |_SYM Dot_NP plot_NN of_IN unstimulated_JJ CD3+_NP lymphocytes_NNS of_IN an_DT individual_NN spontaneously_RB producing_VBG IL-6_NP ._SENT Dot_NN plot_NN of_IN unstimulated_JJ CD3+_NP lymphocytes_NNS of_IN an_DT individual_NN spontaneously_RB producing_VBG IL-6_NP ._SENT FL1_NP ,_, anti-CD8-FITC_NP ;_: FL2_NP ,_, anti-IL-6-PE_NN ._SENT TABLE_NN 1_CD |_SYM Percentages_NNS of_IN cells_NNS staining_VBG with_IN monoclonal_NN antibodies_NNS to_TO various_JJ cytokines_NNS by_IN cell_NN and_CC cytokine_NN types_NNS and_CC spontaneous_JJ cytokine_NN production_NN category_NN Individual_JJ cytokines_NNS and_CC cell_NN types_NNS ._SENT |_SYM Spontaneous_JJ cytokine_NN production_NN was_VBD defined_VBN for_IN seven_CD cytokines_NNS and_CC assessed_VBN in_IN up_IN to_TO seven_CD cell_NN types_NNS ._SENT The_DT numbers_NNS of_IN patients_NNS with_IN cell-specific_JJ spontaneous_JJ cytokine_NN production_NN according_VBG to_TO our_PP$ definition_NN are_VBP provided_VBN in_IN Table_NP ,_, as_RB are_VBP the_DT median_NN and_CC range_NN of_IN the_DT percentage_NN of_IN each_DT cell_NN type_NN producing_VBG each_DT cytokine_NN ._SENT The_DT overlap_VBP in_IN the_DT ranges_NNS between_IN those_DT defined_VBN as_IN being_VBG with_IN and_CC without_IN spontaneous_JJ production_NN is_VBZ due_JJ to_TO differences_NNS in_IN the_DT ranges_NNS for_IN adult_NN and_CC pediatric_JJ patients_NNS and_CC the_DT differences_NNS in_IN the_DT age_NN distributions_NNS of_IN those_DT with_IN and_CC without_IN spontaneous_JJ cytokine_NN production_NN ._SENT Except_IN in_IN the_DT case_NN of_IN IL-6_NP (_( see_VB below_IN )_) ,_, these_DT age-associated_JJ differences_NNS tended_VBN to_TO be_VB slight_JJ and_CC were_VBD not_RB in_IN any_DT consistent_JJ direction_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Our_PP$ definition_NN of_IN spontaneous_JJ cytokine_NN production_NN was_VBD chosen_VBN to_TO be_VB quite_RB conservative_JJ ,_, in_IN that_WDT the_DT lower_JJR limit_NN for_IN spontaneous_JJ production_NN was_VBD in_IN all_DT cases_NNS well_RB over_IN 1_CD %_NN ._SENT The_DT highest_JJS percentages_NNS of_IN any_DT cells_NNS spontaneously_RB producing_VBG a_DT cytokine_NN were_VBD for_IN IL-6_NP ;_: the_DT majority_NN of_IN these_DT instances_NNS were_VBD produced_VBN by_IN the_DT PBMCs_NNS of_IN children_NNS ,_, and_CC the_DT percentages_NNS themselves_PP were_VBD higher_RBR in_IN children_NNS (_( e.g._FW ,_, for_IN CD3+_NP lymphocytes_NNS ,_, the_DT figures_NNS were_VBD as_RB follows_VBZ :_: median_JJ ,_, 69_CD %_NN ;_: range_NN ,_, 68_CD to_TO 71_CD %_NN ;_: n_NN =_SYM 6_CD [_SYM children_NNS ]_SYM versus_IN 21_CD and_CC 61_CD %_NN ,_, n_NN =_SYM 2_CD [_SYM adults_NNS ]_SYM )_) ._SENT The_DT percentages_NNS of_IN cells_NNS producing_VBG IL-6_NP with_IN or_CC without_IN stimulation_NN were_VBD strongly_RB associated_VBN with_IN serum_NN transferrin_NN receptor_NN levels_NNS ,_, an_DT indicator_NN of_IN chronic_JJ iron_NN deficiency_NN ._SENT Using_VBG the_DT definition_NN of_IN spontaneous_JJ cytokine_NN production_NN established_VBN for_IN this_DT study_NN ,_, a_DT slightly_RB higher_JJR proportion_NN of_IN B_NP lymphocytes_NNS than_IN T_NN (_( CD3+_NP )_) lymphocytes_NNS spontaneously_RB produced_VBN IL-4_NN ._SENT The_DT percentages_NNS of_IN CD8-_NP and_CC CD8+_NP T_NN cells_NNS producing_VBG IL-6_NP were_VBD comparable_JJ to_TO one_CD another_DT and_CC higher_JJR than_IN the_DT percentages_NNS of_IN monocytes_NNS producing_VBG IL-6_NP spontaneously_RB ._SENT Immunoregulatory_NP NT_NP cells_NNS were_VBD proportionately_RB highest_JJS in_IN producing_VBG IFN-gamma_NP and_CC TNF-alpha_NP spontaneously_RB ,_, followed_VBD distantly_RB by_IN NK_JJ cells_NNS and_CC CD8+_JJ T_NN cells_NNS ._SENT Using_VBG the_DT definition_NN provided_VBD above_RB ,_, 33_CD of_IN the_DT 62_CD healthy_JJ persons_NNS had_VBD peripheral_JJ blood_NN cells_NNS that_WDT spontaneously_RB produced_VBD one_PP (_( n_NN =_SYM 27_CD persons_NNS )_) ,_, two_CD (_( n_NN =_SYM 5_CD persons_NNS )_) ,_, or_CC three_CD (_( n_NN =_SYM 1_CD person_NN )_) cytokines_NNS ._SENT The_DT T_NN cells_NNS of_IN three_CD healthy_JJ participants_NNS spontaneously_RB produced_VBN IL-2_NP ,_, and_CC those_DT of_IN three_CD spontaneously_RB produced_VBN IL-10_NP ._SENT The_DT B_NP cells_NNS of_IN one_CD healthy_JJ person_NN made_VBD IL-4_NN ._SENT The_DT CD8-_NP T_NN cells_NNS of_IN two_CD healthy_JJ persons_NNS made_VBN IL-8_NP ,_, and_CC those_DT of_IN nine_CD made_VBN IL-6_NP ._SENT The_DT CD8+_NP T_NN cells_NNS of_IN three_CD healthy_JJ persons_NNS made_VBN IL-8_NP ,_, those_DT of_IN three_CD made_VBN IFN-gamma_NP ,_, and_CC those_DT of_IN nine_CD made_VBN IL-6_NP ._SENT The_DT NK_JJ cells_NNS of_IN three_CD healthy_JJ persons_NNS made_VBN TNF-alpha_NP ,_, as_RB did_VBD the_DT NT_JJ cells_NNS of_IN two_CD healthy_JJ persons_NNS ._SENT Monocytes_NNS spontaneously_RB produced_VBN IL-6_NP (_( one_CD healthy_JJ person_NN )_) ,_, IL-8_NP (_( six_CD persons_NNS )_) ,_, IL-10_NP (_( two_CD persons_NNS )_) ,_, or_CC TNF-alpha_NP (_( two_CD persons_NNS )_) ._SENT Thus_RB ,_, for_IN these_DT healthy_JJ persons_NNS ,_, few_JJ made_VBD more_JJR than_IN one_CD cytokine_NN spontaneously_RB and_CC IL-6_NP ,_, not_RB the_DT proinflammatory_JJ cytokine_NN TNF-alpha_NP ,_, was_VBD the_DT cytokine_NN most_RBS commonly_RB made_VBN ._SENT There_EX was_VBD no_DT predominant_JJ cell_NN type_NN making_VBG cytokines_NNS spontaneously_RB ,_, but_CC immunoregulatory_JJ cells_NNS predominated_VBN in_IN spontaneous_JJ TNF-alpha_NP production_NN ._SENT Cytokine_NN and_CC cell_NN type_NN constellations_NNS ._SENT |_SYM Unlike_IN the_DT healthy_JJ participants_NNS ,_, most_JJS patients_NNS producing_VBG cytokines_NNS spontaneously_RB produced_VBD more_JJR than_IN one_CD cytokine_NN type_NN ._SENT For_IN both_CC those_DT spontaneously_RB producing_VBG only_RB one_CD and_CC those_DT spontaneously_RB producing_VBG more_JJR than_IN one_CD cytokine_NN ,_, the_DT cytokine_NN most_RBS frequently_RB made_VBN was_VBD the_DT proinflammatory_JJ cytokine_NN TNF-alpha_NP ,_, followed_VBN by_IN IFN-gamma_NP ._SENT Production_NN of_IN a_DT given_VBN cytokine_NN by_IN multiple_JJ cell_NN types_NNS was_VBD frequent_JJ but_CC did_VBD not_RB occur_VB in_IN the_DT majority_NN of_IN cases_NNS ._SENT For_IN example_NN ,_, for_IN IL-4_NN ,_, 4_CD patients_NNS had_VBD both_DT T_NN and_CC B_NN cells_NNS spontaneously_RB producing_VBG the_DT cytokine_NN while_IN a_DT total_NN of_IN 18_CD patients_NNS had_VBD T_NN cells_NNS and_CC 17_CD had_VBD B_NN cells_NNS spontaneously_RB producing_VBG it_PP ._SENT Similarly_RB ,_, three_CD patients_NNS had_VBD both_DT T_NN cells_NNS and_CC monocytes_NNS producing_VBG IL-6_NP and_CC five_CD had_VBD both_DT CD8-_NP and_CC CD8+_NP T_NN cells_NNS making_VBG IL-6_NP ._SENT For_IN IL-8_NP ,_, these_DT values_NNS were_VBD four_CD and_CC six_CD patients_NNS ,_, respectively_RB ._SENT Four_CD patients_NNS had_VBD both_DT CD8-_NP and_CC CD8+_NP T_NN cells_NNS spontaneously_RB producing_VBG IFN-gamma_NP ._SENT The_DT overlap_VBP was_VBD greatest_JJ between_IN NT_JJ and_CC NK_JJ cells_NNS ,_, with_IN fully_RB half_JJ (_( nine_CD patients_NNS )_) of_IN those_DT producing_VBG IFN-gamma_NP spontaneously_RB in_IN NT_JJ or_CC NK_JJ cells_NNS producing_VBG it_PP in_IN both_CC these_DT immunoregulatory_JJ cell_NN populations_NNS ._SENT This_DT was_VBD not_RB the_DT case_NN for_IN TNF-alpha_NP ,_, of_IN which_WDT only_JJ two_CD patients_NNS had_VBD spontaneous_JJ production_NN in_IN both_DT NT_JJ and_CC NK_JJ cells_NNS ._SENT Thirteen_CD adult_JJ patients_NNS and_CC nine_CD children_NNS had_VBD two_CD to_TO eight_CD combinations_NNS of_IN cells_NNS spontaneously_RB producing_VBG type_NN 1_CD cytokines_NNS without_IN any_DT cell_NN type_NN spontaneously_RB producing_VBG any_DT type_NN 2_CD cytokine_NN ._SENT Conversely_RB ,_, five_CD adult_NN patients_NNS and_CC seven_CD children_NNS had_VBD two_CD to_TO five_CD combinations_NNS of_IN cells_NNS spontaneously_RB producing_VBG type_NN 2_CD cytokines_NNS without_IN any_DT cell_NN type_NN spontaneously_RB producing_VBG any_DT type_NN 1_CD cytokine_NN ._SENT Nineteen_CD adult_JJ patients_NNS and_CC 17_CD children_NNS had_VBD both_DT one_CD to_TO six_CD combinations_NNS of_IN cells_NNS spontaneously_RB producing_VBG type_NN 1_CD cytokines_NNS and_CC one_CD to_TO five_CD combinations_NNS of_IN cells_NNS spontaneously_RB producing_VBG type_NN 2_CD cytokines_NNS ._SENT Four_CD adult_JJ patients_NNS and_CC six_CD children_NNS had_VBD two_CD to_TO six_CD cell_NN types_NNS spontaneously_RB producing_VBG TNF-alpha_NP and_CC IL-8_NP ;_: two_CD adult_NN patients_NNS and_CC four_CD children_NNS had_VBD two_CD or_CC three_CD cell_NN types_NNS spontaneously_RB producing_VBG IL-4_NN and/or_CC IL-10_NP ._SENT For_IN healthy_JJ participants_NNS ,_, the_DT mix_NN of_IN cell_NN types_NNS spontaneously_RB producing_VBG a_DT given_VBN cytokine_NN was_VBD similar_JJ to_TO that_DT of_IN the_DT patients_NNS ._SENT For_IN six_CD persons_NNS ,_, both_CC the_DT CD8+_NP and_CC CD8-_NP T_NN cells_NNS spontaneously_RB produced_VBN IL-6_NP ;_: for_IN three_CD persons_NNS each_DT ,_, only_RB CD8-_NP or_CC CD8+_NP T_NN cells_NNS spontaneously_RB produced_VBN IL-6_NP ;_: and_CC for_IN one_CD person_NN ,_, only_RB monocytes_NNS spontaneously_RB produced_VBN IL-6_NP ._SENT For_IN two_CD persons_NNS ,_, both_CC CD8+_NP and_CC CD8-_NP T_NN cells_NNS spontaneously_RB produced_VBN IL-8_NP ;_: for_IN one_CD person_NN ,_, only_JJ CD8+_NP T_NN cells_NNS spontaneously_RB produced_VBN IL-8_NP ;_: and_CC for_IN six_CD persons_NNS ,_, only_RB monocytes_NNS spontaneously_RB produced_VBN IL-8_NP ._SENT For_IN three_CD healthy_JJ persons_NNS ,_, only_JJ T_NN cells_NNS spontaneously_RB made_VBN IL-10_NP ,_, and_CC for_IN two_CD persons_NNS ,_, only_RB monocytes_NNS spontaneously_RB made_VBN IL-10_NP ._SENT For_IN three_CD healthy_JJ persons_NNS ,_, only_RB NK_JJ cells_NNS spontaneously_RB made_VBN TNF-alpha_NP ;_: for_IN one_CD person_NN ,_, only_RB NT_JJ cells_NNS spontaneously_RB made_VBN TNF-alpha_NP ;_: for_IN one_CD person_NN ,_, only_RB monocytes_NNS spontaneously_RB made_VBN TNF-alpha_NP ;_: and_CC for_IN one_CD person_NN ,_, monocytes_NNS and_CC NT_JJ cells_NNS spontaneously_RB made_VBN TNF-alpha_NP ._SENT Of_IN the_DT six_CD healthy_JJ persons_NNS producing_VBG more_JJR than_IN one_CD cytokine_NN spontaneously_RB ,_, two_CD made_VBD both_DT IL-6_NP and_CC TNF-alpha_NP ,_, one_PP made_VBD IL-6_NP and_CC IL-10_NP ,_, one_PP made_VBD IL-8_NP and_CC IL-10_NP ,_, one_PP made_VBD IL-8_NP and_CC TNF-alpha_NP ,_, and_CC one_CD made_VBN IL-4_NN ,_, IL-8_NP ,_, and_CC IFN-gamma_NP ._SENT Effects_NNS of_IN spontaneous_JJ cytokine_NN production_NN on_RB induced_VBD (_( stimulated_VBN )_) production_NN by_IN the_DT same_JJ cell_NN type_NN ._SENT |_SYM For_IN IL-2_NP ,_, IL-4_NN ,_, IL-6_NP ,_, IL-8_NP ,_, and_CC IL-10_NP ,_, spontaneous_JJ cytokine_NN production_NN by_IN a_DT given_VBN cell_NN type_NN tended_VBD to_TO be_VB or_CC was_VBD significantly_RB associated_VBN with_IN a_DT higher_JJR percentage_NN of_IN the_DT same_JJ cell_NN type_NN producing_VBG the_DT same_JJ cytokine_NN with_IN stimulation_NN ,_, with_IN the_DT single_JJ exception_NN of_IN children_NNS 's_POS T-cell_NN production_NN of_IN IL-4_NN ,_, for_IN which_WDT there_EX was_VBD a_DT nonsignificant_JJ trend_NN in_IN the_DT opposite_JJ direction_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Findings_NNS for_IN IFN-gamma_NP varied_VBD by_IN cell_NN type_NN ,_, with_IN NK_JJ and_CC NT_JJ responding_VBG in_IN a_DT pattern_NN similar_JJ to_TO those_DT of_IN other_JJ cytokines_NNS ,_, CD3+_NP CD8-_NP cells_NNS without_IN an_DT obvious_JJ effect_NN ,_, and_CC the_DT percentage_NN of_IN CD3+_NP CD8+_NP cells_NNS producing_VBG IFN-gamma_NP with_IN stimulation_NN being_VBG lower_JJR in_IN those_DT for_IN whom_WP this_DT cell_NN type_NN was_VBD spontaneously_RB producing_VBG the_DT cytokine_NN ._SENT For_IN TNF-alpha_NP ,_, the_DT only_JJ significant_JJ effect_NN was_VBD found_VBN in_IN NK_JJ cells_NNS ,_, again_RB in_IN a_DT positive_JJ direction_NN ._SENT These_DT trends_NNS were_VBD present_JJ in_IN both_DT adult_NN and_CC pediatric_JJ patients_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT numbers_NNS of_IN healthy_JJ participants_NNS making_VBG cytokines_NNS spontaneously_RB were_VBD too_RB small_JJ for_IN statistical_JJ analyses_NNS ,_, except_IN in_IN the_DT cases_NNS of_IN IL-6_JJ production_NN by_IN T_NN cells_NNS and_CC IL-8_JJ production_NN by_IN monocytes_NNS (_( see_VB below_IN )_) ._SENT The_DT trends_NNS were_VBD in_IN the_DT same_JJ direction_NN found_VBN with_IN the_DT patients_NNS ,_, except_IN that_DT spontaneous_JJ production_NN of_IN IL-10_NP by_IN T_NN cells_NNS did_VBD not_RB affect_VB induced_VBN production_NN (_( data_NNS not_RB shown_VBN )_) ._SENT In_IN healthy_JJ persons_NNS ,_, as_RB in_IN the_DT patients_NNS ,_, the_DT percentage_NN of_IN each_DT cell_NN type_NN producing_VBG IL-6_NP with_IN induction_NN was_VBD significantly_RB higher_JJR in_IN those_DT with_IN spontaneous_JJ IL-6_NP production_NN than_IN in_IN those_DT without_IN spontaneous_JJ production_NN (_( medians_NNS for_IN CD8-_NP T_NN cells_NNS ,_, 9.3_CD versus_CC 0.3_CD %_NN [_SYM P_NN <_SYM 0.001_CD ]_SYM ,_, and_CC for_IN CD8+_NP T_NN cells_NNS ,_, 7.6_CD versus_CC 1.2_CD %_NN [_SYM P_NN <_SYM 0.001_CD ]_SYM )_) ._SENT As_RB with_IN patients_NNS ,_, the_DT spontaneous_JJ production_NN of_IN IL-8_NP by_IN monocytes_NNS did_VBD not_RB have_VB a_DT significant_JJ effect_NN on_IN the_DT percentages_NNS of_IN monocytes_NNS producing_VBG IL-8_NP with_IN induction_NN (_( 74.2_CD versus_IN 58.3_CD %_NN ;_: P_NN =_SYM 0.398_CD )_) ._SENT Effects_NNS of_IN spontaneous_JJ cytokine_NN production_NN on_RB induced_VBD (_( stimulated_VBN )_) production_NN by_IN other_JJ cell_NN types_NNS ._SENT |_SYM We_PP next_RB sought_VBD evidence_NN of_IN intercellular_JJ regulation_NN of_IN cytokine_NN production_NN by_IN examining_VBG the_DT relationships_NNS between_IN spontaneous_JJ production_NN of_IN a_DT cytokine_NN by_IN one_CD cell_NN type_NN and_CC the_DT induced_VBN production_NN of_IN that_DT same_JJ cytokine_NN by_IN another_DT cell_NN type_NN ._SENT Few_JJ relationships_NNS were_VBD found_VBN ;_: those_DT for_IN IL-4_NN ,_, IL-6_NP ,_, and_CC IFN-gamma_NP were_VBD in_IN a_DT positive_JJ direction_NN ._SENT For_IN two_CD proinflammatory_JJ cytokines_NNS ,_, IL-8_NP and_CC TNF-alpha_NP ,_, in_IN adults_NNS but_CC not_RB in_IN children_NNS ,_, the_DT spontaneous_JJ production_NN of_IN a_DT cytokine_NN was_VBD associated_VBN with_IN a_DT lower_JJR percentage_NN of_IN another_DT cell_NN type_NN producing_VBG that_DT cytokine_NN with_IN stimulation_NN ._SENT This_DT was_VBD especially_RB the_DT case_NN for_IN TNF-alpha_NP ._SENT Findings_NNS for_IN adult_NN and_CC pediatric_JJ patients_NNS were_VBD similar_JJ to_TO one_CD another_DT in_IN regard_NN to_TO the_DT other_JJ cytokines_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT For_IN healthy_JJ participants_NNS ,_, the_DT effects_NNS of_IN spontaneous_JJ production_NN of_IN IL-6_NP on_IN induced_VBN production_NN by_IN other_JJ cell_NN types_NNS were_VBD similar_JJ to_TO those_DT for_IN the_DT patients_NNS ._SENT For_IN example_NN ,_, for_IN healthy_JJ persons_NNS ,_, the_DT median_JJ percentages_NNS of_IN CD8-_NP T_NN cells_NNS and_CC of_IN monocytes_NNS making_VBG IL-6_NP with_IN induction_NN were_VBD higher_JJR for_IN those_DT whose_WP$ CD8+_NP T_NN cells_NNS made_VBD IL-6_NP spontaneously_RB than_IN for_IN those_DT whose_WP$ CD8+_NP T_NN cells_NNS did_VBD not_RB make_VB IL-6_JJ spontaneously_RB (_( 7.4_CD versus_IN 0.3_CD %_NN [_SYM P_NN <_SYM 0.001_CD ]_SYM and_CC 12.2_CD versus_CC 1.0_CD %_NN [_SYM P_NN <_0.001], =1_JJ cytokine_NN TABLE_NP 3_CD |_SYM Median_JJ percentages_NNS of_IN cells_NNS expressing_VBG cytokine_NN with_IN stimulation_NN ,_, by_IN presence_NN or_CC absence_NN of_IN spontaneous_JJ production_NN of_IN that_DT cytokine_JJ TABLE_NP 4_CD |_SYM Median_JJ percentages_NNS of_IN cells_NNS producing_VBG cytokine_NN with_IN stimulation_NN ,_, by_IN presence_NN or_CC absence_NN of_IN spontaneous_JJ production_NN of_IN that_DT cytokine_NN by_IN a_DT different_JJ cell_NN type_NN We_PP report_VBP here_RB that_IN the_DT peripheral_JJ blood_NN cells_NNS of_IN some_DT hospitalized_VBN and_CC some_DT apparently_RB healthy_JJ persons_NNS in_IN Malawi_NP produced_VBD cytokines_NNS ex_JJ vivo_RB without_IN additional_JJ stimulation_NN ._SENT Spontaneous_JJ ex_JJ vivo_JJ cytokine_NN production_NN by_IN peripheral_JJ blood_NN cells_NNS rarely_RB occurs_VBZ in_IN healthy_JJ U.S._NP or_CC European_JJ individuals_NNS or_CC even_RB in_IN those_DT with_IN a_DT wide_JJ variety_NN of_IN chronic_JJ and/or_CC systemic_JJ diseases_NNS ,_, including_VBG allergic_JJ asthma_NN ,_, collagen_NN vascular_JJ diseases_NNS ,_, and_CC sarcoidosis_NN ._SENT The_DT clinical_JJ and_CC demographic_JJ characteristic_NN of_IN the_DT Malawi_NP patients_NNS spontaneously_RB producing_VBG cytokines_NNS will_MD be_VB discussed_VBN elsewhere_RB ,_, but_CC suffice_VB it_PP to_TO say_VB ,_, these_DT participants_NNS were_VBD not_RB analogous_JJ to_TO healthy_JJ U.S._NP blood_NN donors_NNS ._SENT HIV_NP ,_, malaria_NN ,_, numerous_JJ intestinal_JJ parasites_NNS ,_, and_CC mycobacterial_JJ infections_NNS are_VBP all_RB endemic_JJ in_IN Malawi_NP ._SENT In_IN addition_NN ,_, by_IN the_DT enrollment_NN criteria_NNS ,_, the_DT patients_NNS in_IN this_DT study_NN were_VBD acutely_RB ill_JJ ._SENT Since_IN there_EX is_VBZ great_JJ interest_NN in_IN the_DT roles_NNS of_IN cytokines_NNS in_IN acute_JJ and_CC chronic_JJ infections_NNS ,_, spontaneous_JJ cytokine_NN production_NN by_IN the_DT peripheral_JJ blood_NN cells_NNS of_IN persons_NNS within_IN our_PP$ study_NN population_NN warranted_VBD further_JJR investigation_NN ._SENT We_PP therefore_RB examined_VBD data_NNS from_IN these_DT Malawi_NP patients_NNS and_CC the_DT ostensibly_RB healthy_JJ individuals_NNS to_TO characterize_VB this_DT previously_RB unstudied_JJ phenomenon_NN and_CC to_TO assess_VB its_PP$ relationship_NN to_TO induced_VBN cell-specific_JJ cytokine_NN production_NN ._SENT By_IN the_DT criteria_NNS used_VBN ,_, spontaneous_JJ cytokine_NN production_NN was_VBD not_RB rare_JJ in_IN this_DT study_NN group_NN and_CC often_RB involved_VBN NK_JJ and_CC NT_JJ cells_NNS ,_, two_CD immunoregulatory_JJ cell_NN populations_NNS important_JJ in_IN mycobacterial_NP and_CC HIV_NP infections_NNS but_CC only_RB infrequently_RB examined_VBN in_IN clinical_JJ studies_NNS ._SENT TNF-alpha_NP ,_, a_DT proinflammatory_JJ cytokine_NN ,_, was_VBD the_DT cytokine_NN most_RBS often_RB produced_VBN spontaneously_RB by_IN patients_NNS ,_, consistent_JJ with_IN these_DT patients_NN having_VBG acute_JJ inflammation_NN ._SENT The_DT type_NN 1_CD cytokine_NN IFN-gamma_NP was_VBD next_JJ in_IN frequency_NN ,_, often_RB being_VBG made_VBN by_IN NK_JJ and_CC NT_JJ cells_NNS ,_, followed_VBN by_IN the_DT chemokine_NP IL-8_NP ,_, which_WDT activates_VBZ neutrophils_NNS and_CC neutrophil_JJ adhesion_NN to_TO vascular_JJ endothelium_NN ._SENT This_DT order_NN appears_VBZ reasonable_JJ given_VBN the_DT participants_NNS '_POS acutely_RB ill_JJ state_NN and_CC the_DT frequency_NN of_IN HIV_NP and_CC mycobacterial_JJ infections_NNS in_IN this_DT population_NN ._SENT Spontaneous_JJ production_NN of_IN type_NN 2_CD cytokines_NNS was_VBD less_RBR frequent_JJ than_IN that_DT of_IN the_DT proinflammatory_NN and_CC type_NN 1_CD cytokines_NNS ,_, and_CC a_DT higher_JJR proportion_NN of_IN patients_NNS spontaneously_RB produced_VBD the_DT type_NN 2_CD cytokine_NN IL-4_NN than_IN the_DT type_NN 2_CD cytokine_NN IL-10_NN ._SENT Production_NN of_IN a_DT given_VBN cytokine_NN by_IN one_CD cell_NN type_NN was_VBD not_RB necessarily_RB associated_VBN with_IN production_NN by_IN other_JJ cell_NN types_NNS ;_: however_RB ,_, most_JJS patients_NNS who_WP produced_VBD cytokines_NNS spontaneously_RB produced_VBD more_JJR than_IN one_CD type_NN of_IN cytokine_NN ._SENT For_IN the_DT healthy_JJ individuals_NNS ,_, IL-6_NP was_VBD the_DT cytokine_NN most_RBS frequently_RB produced_VBN spontaneously_RB ,_, and_CC spontaneous_JJ production_NN of_IN a_DT single_JJ cytokine_NN was_VBD the_DT rule_NN ,_, not_RB the_DT exception_NN ._SENT Spontaneous_JJ cytokine_NN production_NN has_VBZ both_DT physiologic_JJ and_CC practical_JJ implications_NNS ._SENT Cytokines_NNS affect_VBP infectious-disease_NN morbidity_NN and_CC mortality_NN and_CC the_DT interaction_NN between_IN various_JJ opportunistic_JJ infections_NNS and_CC HIV_NP ._SENT Presumably_RB ,_, spontaneous_JJ ex_JJ vivo_JJ cytokine_NN production_NN reflects_VBZ in_IN vivo_JJ stimulation_NN and_CC thus_RB represents_VBZ cell-specific_JJ activity_NN in_IN the_DT context_NN of_IN a_DT current_JJ infection(s)_NN and/or_CC physical_JJ condition_NN and_CC in_IN the_DT actual_JJ natural_JJ milieu_NN of_IN that_DT cell_NN ._SENT Consistent_JJ with_IN this_DT assumption_NN ,_, in_IN previous_JJ assessments_NNS of_IN this_DT Malawian_JJ study_NN group_NN we_PP found_VBD spontaneous_JJ IFN-gamma_NP production_NN by_IN NT_JJ cells_NNS to_TO be_VB associated_VBN with_IN mortality_NN and_CC the_DT spontaneous_JJ production_NN of_IN a_DT number_NN of_IN other_JJ cytokines_NNS by_IN various_JJ cell_NN types_NNS to_TO be_VB associated_VBN with_IN malaria_NN parasitemia_NN ,_, iron_NN deficiency_NN ,_, or_CC vitamin_NN A_DT deficiency_NN ._SENT In_IN nonhospitalized_JJ HIV-infected_JJ persons_NNS in_IN the_DT United_NP States_NPS ,_, we_PP found_VBD significant_JJ declines_NNS in_IN spontaneous_JJ TNF-alpha_NP and_CC IL-4_NN production_NN by_IN T_NN cells_NNS to_TO be_VB associated_VBN with_IN the_DT acute_JJ response_NN to_TO highly_RB active_JJ antiretroviral_JJ therapy_NN ._SENT These_DT previously_RB published_VBN data_NNS support_VBP the_DT potential_JJ physiological_JJ importance_NN of_IN measurable_JJ spontaneous_JJ cytokine_NN production_NN ._SENT However_RB ,_, we_PP and_CC many_JJ others_NNS have_VBP also_RB reported_VBN significant_JJ relationships_NNS between_IN induced_VBN cytokine_NN production_NN and_CC a_DT wide_JJ variety_NN of_IN illnesses_NNS and_CC physiologic_JJ states_NNS ._SENT Thus_RB ,_, we_PP were_VBD concerned_VBN about_RB whether_IN spontaneous_JJ cytokine_NN production_NN might_MD obscure_VB or_CC alter_VB the_DT more_RBR commonly_RB measured_VBN induced_VBN cytokine_NN production_NN ._SENT Ex_JJ vivo_JJ induction_NN theoretically_RB expands_VBZ a_DT stimulated_VBN population_NN to_TO measurable_JJ levels_NNS ;_: however_RB ,_, human_JJ data_NNS to_TO support_VB the_DT idea_NN that_IN this_DT expanded_JJ population_NN is_VBZ representative_JJ of_IN in_IN vivo_JJ cell-specific_JJ cytokine_NN profiles_NNS are_VBP sparse_JJ at_IN best_JJS ._SENT As_RB with_IN measurements_NNS of_IN serum_NN cytokine_NN levels_NNS ,_, the_DT underlying_VBG assumption_NN is_VBZ that_IN peripheral-blood_NN findings_NNS are_VBP of_IN importance_NN in_IN systemic_JJ ,_, or_CC even_RB localized_VBN ,_, diseases_NNS ._SENT This_DT is_VBZ somewhat_RB of_IN an_DT assumption_NN in_IN regard_NN to_TO both_DT measures_NNS ._SENT We_PP have_VBP previously_RB shown_VBN that_IN ,_, in_IN general_NN ,_, serum_NN and_CC cell-specific_JJ cytokines_NNS are_VBP at_IN best_JJS only_RB weakly_RB associated_VBN with_IN one_CD another_DT ._SENT Correlations_NNS between_IN cell_NN and_CC serum_NN cytokine_NN parameters_NNS were_VBD not_RB infrequently_RB even_RB negative_JJ ,_, consistent_JJ with_IN the_DT hypothesis_NN that_IN serum_NN and_CC cell-specific_JJ cytokines_NNS measure_VB different_JJ things_NNS ._SENT Interestingly_RB ,_, for_IN the_DT patients_NNS with_IN spontaneous_JJ cytokine_NN production_NN discussed_VBD here_RB ,_, the_DT correlations_NNS between_IN serum_NN and_CC peripheral-blood_JJ cell-specific_JJ cytokines_NNS were_VBD all_RB in_IN a_DT positive_JJ direction_NN but_CC ,_, as_RB with_IN the_DT more_RBR general_JJ population_NN ,_, generally_RB with_IN only_JJ weak_JJ correlation_NN coefficients_NNS (_( this_DT study_NN )_) ._SENT Theoretically_RB ,_, if_IN cells_NNS have_VBP been_VBN stimulated_VBN by_IN in_IN vivo_JJ antigen_NN exposure_NN ,_, secondary_JJ ex_JJ vivo_JJ induction_NN with_IN phorbol_NN esters_NNS could_MD lead_VB to_TO in_IN vitro_NN apoptosis_NN and_CC obscure_VB the_DT role_NN of_IN that_DT cell-specific_JJ cytokine_NN in_IN the_DT physiologic_JJ process_NN ._SENT This_DT would_MD be_VB analogous_JJ to_TO measuring_VBG expression_NN of_IN variable_JJ beta-chain_NN families_NNS of_IN the_DT T-cell_NN receptor_NN too_RB long_RB after_IN superantigen_NN stimulation_NN ._SENT In_IN this_DT Malawi_NP study_NN ,_, we_PP found_VBD that_IN in_IN many_JJ instances_NNS ,_, spontaneous_JJ cytokine_NN production_NN was_VBD not_RB associated_VBN with_IN a_DT significant_JJ difference_NN in_IN induced_VBN production_NN ._SENT When_WRB a_DT relationship_NN was_VBD found_VBN ,_, it_PP was_VBD usually_RB in_IN a_DT positive_JJ direction_NN ,_, not_RB a_DT negative_JJ one_CD ,_, as_RB would_MD have_VB been_VBN expected_VBN with_IN apoptosis_NN ._SENT IL-6_NP findings_NNS were_VBD especially_RB interesting_JJ in_IN this_DT regard_NN ._SENT They_PP strongly_RB followed_VBD the_DT described_VBN pattern_NN ;_: however_RB ,_, for_IN this_DT cytokine_NN ,_, the_DT cell_NN percentages_NNS were_VBD actually_RB higher_JJR for_IN unstimulated_VBN than_IN for_IN induced_VBN cells_NNS (_( e.g._FW ,_, for_IN patients_NNS '_POS CD3+_NP CD8+_NP cells_NNS ,_, the_DT medians_NNS were_VBD 85.9_CD versus_IN 53.7_CD %_NN )_) ,_, suggesting_VBG that_IN some_DT degree_NN of_IN activation-associated_JJ cell_NN death_NN might_MD have_VB been_VBN taking_VBG place_NN but_CC that_DT cell_NN division_NN and_CC cytokine_NN induction_NN were_VBD generally_RB keeping_VBG in_IN balance_NN with_IN the_DT negative_JJ process_NN ._SENT Further_RBR ,_, this_DT IL-6_NP finding_NN strongly_RB suggests_VBZ that_IN the_DT cytokine_NN was_VBD far_RB more_RBR strongly_RB induced_VBN by_IN events_NNS occurring_VBG in_IN vivo_RB ,_, e.g._FW ,_, iron_NN deficiency_NN ,_, than_IN by_IN the_DT stimulation_NN provided_VBN in_IN vitro_NN ._SENT Finally_RB ,_, evidence_NN of_IN down_JJ modulation_NN of_IN induced_VBN cytokine_NN production_NN by_IN one_CD cell_NN type_NN in_IN the_DT presence_NN of_IN spontaneous_JJ production_NN by_IN a_DT different_JJ cell_NN type_NN was_VBD found_VBN only_RB for_IN TNF-alpha_NP (_( among_IN T_NN ,_, NT_NP ,_, and_CC NK_JJ cells_NNS )_) for_IN adult_NN patients_NNS ._SENT In_IN conclusion_NN ,_, spontaneous_JJ cytokine_NN production_NN ,_, albeit_IN unusual_JJ in_IN industrialized_JJ societies_NNS ,_, can_MD occur_VB in_IN some_DT individuals_NNS and_CC may_MD not_RB be_VB that_IN unusual_JJ in_IN persons_NNS in_IN developing_VBG 